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Summary  Today,  because  systemic  infections  such  as  urinary  tract  infection  (UTI)
affect  even  pediatric  patients,  antibiotic  resistant  bacteria  have  become  a  constant
clinical  challenge.  In  the  present  study,  a total  of  1054  urine  samples  were  col-
lected  from  pediatric  patients  over  18  months.  From  these  samples,  510  isolates  of
pathogenic  bacteria  were  collected  using  HiCrome  UTI  agar.  Antibiotic  sensitivity
tests  of  isolates  were  performed  using  the  Kirby—Bauer  method.  Two  Gram-positive
bacteria  (Enterococcus  faecalis  and  Staphylococcus  aureus) and  7  Gram-negative
bacteria  (Citrobacter  freundii,  Enterobacter  aerogenes, Escherichia  coli,  Kleb-
siella  oxytoca,  K.  pneumoniae, Proteus  vulgaris  and  Pseudomonas  aeruginosa) were
isolated.  Antibiograms  of  isolated  bacteria  were  ascertained  using  antibiotics  of
4  classes:  aminoglycosides,  -lactams,  ﬂuoroquinolones  and  2  stand-alones  (co-
trimoxazole  and  nitrofurantoin).  Based  on  percent  values  of  antibiotic  resistance,
isolated  bacteria  were  (in  decreasing  order  of  number  of  isolated  isolates):  E.
coli  (109)  >  S.  aureus  (65)  >  E.  faecalis  (82)  >  E.  aerogenes  (64)  >  C.  freundii  (41)  >  P.
aeruginosa  (32)  >  K.  pneumoniae  (45)  >  K.  oxytoca  (50)  >  P.  vulgaris  (22).  Surveil-
lance  results  show  that  MDR  isolates  of  9  pathogenic  bacteria  were  prevalent  in
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rinary  tract  infection  (UTI)  is  deﬁned  by  the  pres-
nce of  a  threshold  number  of  pathogenic  bacteria
105 CFU/mL)  in  urine.  Invasive/progressive  infec-
ions of  the  tract  with  a  higher  bacterial  population
ause cystitis,  urethritis  and  pyelonephritis.  Symp-
oms of  UTI  in  children  include  hematuria,  dysuria,
loudy  urine  and  nocturnal  enuresis,  sometimes
ssociated with  nausea  and  vomiting  along  with
ever  [1,2].  Febrile  young  female  children  without
roper  toilet  training,  infants  with  vesicoureteral
eﬂux and  tight  phimosis  are  at  risk  for  UTI.  The
esultant blood  stream  infection  can  lead  to  fatal
acteremia,  with  symptoms  ranging  from  skin  reac-
ions, subcutaneous  nodules,  metastatic  abscesses,
nd meningitis,  etc.,  which  may  lead  to  terminal
llness [3—5].  UTI  is  often  associated  with  other  ail-
ents such  as  acute  respiratory  infection  and  acute
iarrhea.  Due  to  the  vague  clinical  manifestation
n children  and  infants,  basic  ﬁrst  level  diagnostic
ests of  urine  are  not  advised  regularly  in  develop-
ng countries,  thus,  UTI  is  not  reported  as  a  cause
f childhood  morbidity.
Antibiotics  are  frequently  prescribed  every-
here in  both  empiric  and  regular  therapy  for  UTI
6].  At  the  hospital  in  the  present  study,  UTIs  were
f serious  clinical  concern  for  adult  patients  due
o causative  multidrug  resistant  (MDR)  bacteria,
hich are  resistant  to  routinely  used  antibiotics  [7].
his hospital  reported  that  in  an  18  month  period,
 Gram-positives  (GPs)  (Enterococcus  faecalis  and
taphylococcus  aureus)  and  9  Gram-negatives  (GNs)
Acinetobacter  baumannii, Citrobacter  freundii,
nterobacter  aerogenes, Escherichia  coli,  Kleb-
iella oxytoca,  K.  pneumoniae, Proteus  mirabilis,
. vulgaris  and  Pseudomonas  aeruginosa) were
solated  as  uropathogens  from  hospitalized  and
ommunity  adult  patients  attending  the  hospital
7].  Device  and  fomite  associated  nosocomial  infec-
ions in  hospitals  are  important  factors  related  to
athogenic  spread.
As  an  extension  of  previous  research  on  adults
onducted in  2011—2012  [7], this  study  was  under-
aken  in  2013—2014  with  pediatric  UTI  patients  who
ere visiting  the  outpatient  department  (OPD)  and
A
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ospital.  Thus,  revisions  to  the  antimicrobial  stewardship
country  are  required  to  increase  clinician  conﬁdence  in
en  used  for  UTI  cases.
ziz  University  for  Health  Sciences.  Published  by  Elsevier
ho  were  admitted  to  wards,  cabins  and  neona-
al intensive  care  unit  designated  as  inpatient
epartments (IPD)  over  a  period  of  18  months.
his study  was  undertaken  to  explore  possibili-
ies for  a revision  of  the  antimicrobial  stewardship
rogram because  the  rising  concern  caused  by  fre-
uent UTI  reports  in  adults  and  children  could
e addressed  with  a newer  prophylaxis  module.  A
evised antimicrobial  stewardship  program  would
educe  nosocomial  spread  of  certain  isolates  of
acteria  reported  earlier  from  this  hospital  [8—10]
s  well  as  morbidity  and  hospitalization  costs.
bviously, empiric  therapy  is  usually  formulated
n epidemiological  data  based  on  regional  surveil-
ance reports;  however,  the  spread  of  drug  resistant
acteria  may  undermine  empiric  therapy.  The
resent  study  should  help  inform  empiric  therapy
or preventing  child  mortality  from  UTI  and  enteric
nfections  in  India  [11].
ethods
solation and identiﬁcation of pathogenic
acteria
ver  a  span  of  18  months  (January  2013  to  June
014) 510  isolates  of  pathogenic  bacteria  belonging
o 9  genera  (2  GP  and  7 GN  bacteria)  were  iso-
ated by  culturing  1054  urine  samples  of  OPD  and
PD pediatric  patients  attending/admitted  to  the
nstitute of  Medical  Sciences  and  Sum  Hospital  with
omplaints  of  fever  and  foul  urine.  Strains  were
dentiﬁed using  media,  HiCrome  UTI  agar  (HiMe-
ia, Mumbai)  and  standard  biochemical  tests  [7]
nd  were  maintained  as  pure  cultures  in  nutri-
nt agar  (HiMedia).  Corresponding  Microbial  Type
ulture  Collection  (MTCC)  strains  were  used  as  ref-
rence controls  during  biochemical  identiﬁcation  of
solated bacteria.  Two  GPs  and  7  GNs  were  isolated
rom  culturing  urine  samples  and  were  used  in  this
tudy (Table  1).
ntibiotic susceptibility testll  bacterial  isolates  including  the  standard  isolates
rom MTCC  of  each  bacterium  were  subjected  to
310  M.P.  Mishra  et  al.
Table  1  Bacteria  isolated  from  urine  samples  of  IPD  and  OPD  pediatric  patients.
Bacteria  MTCC  strain
number
January—June
2013
July—December
2013
January—June
2014
Total
Enterococcus  faecalis  439  20  27  35  82
Staphylococcus  aureus  7443  15  22  28  65
Citrobacterfreundii  1658  14  18  09  41
Enterobacter  aerogenes 2990  22  27  15  64
Escherichia  coli 443  48  25  36  109
Klebsiella  oxytoca 2275  16  22  12  50
Klebsiella  pneumoniae 4031  12  15  18  45
Proteus  vulgaris  1771  10  7  5  22
Pseudomonas  aeruginosa  1688  14  10  08  32
Grand  total  171  173  166  510
— Microbial Type Culture Collection strains were used as reference
 IPD, inpatient department; OPD, outpatients department.
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controls during biochemical identiﬁcation of isolated bacteria;
antibiotic  sensitivity  tests  by  Kirby—Bauer/disk  dif-
fusion method,  using  a  4 mm  thick  Mueller—Hinton
agar (HiMedia)  medium  [7,12].  Fifteen  prescribed
antibiotics of  4  groups  were  used.  Plates  were  incu-
bated for  18  h  at  37 ◦C  and  were  examined  for
size-measurements  of  zones  of  inhibition  around
each disk,  following  the  standard  antibiotic  sus-
ceptibility  test  chart  of  CLSI  guidelines  [12]. The
susceptibility  limit  of  resistance  was  above  20  mm
in agar  plates.
Results
Overall,  510  isolates  of  pathogenic  bacteria  belong-
ing to  two  GPs  and  seven  GNs  were  collected  from
a total  of  1054  urine  samples  from  community  OPD
and IPD  pediatric  patients  over  18  months.  In  total,
there were  82  isolates  of  E.  faecalis;  65  isolates
of S.  aureus;  41  isolates  of  C.  freundii;  64  iso-
lates of  E.  aerogenes;  109  isolates  of  E.  coli;  50
isolates of  K.  oxytoca;  45  isolates  of  K.  pneumo-
niae; 22  isolates  of  P.  vulgaris;  and  32  isolates  of  P.
aeruginosa.  Based  on  the  isolate  numbers,  bacte-
ria could  be  arranged  in  the  following  decreasing
order: E.  coli  >  E.  faecalis  >  S.  aureus  >  E.  aero-
genes >  K.  oxytoca  >  K.  pneumoniae  >  C.  freundii  > P.
aeruginosa >  P.  vulgaris  (Table  1).
From 510  positive  samples  in  the  1—12  month
age group,  120  samples  were  collected  from  which
72 samples  were  from  males  and  48  samples  were
from  females.  In  the  1—5  year  age  group,  there
was a  total  of  144  positive  samples  were  collected
from 60  males  and  84  females.  In  the  6—15  year  age
group,  246  clinical  samples  were  collected  92  males
and 154  female  patients.  These  results  indicate
that in  the  age  group  of  1—12  months,  males  were
more predisposed  to  UTI  than  females.  However,
v
1
E
aigure  1  Prevalence  of  UTI  in  pediatric  patients  over  an
8  month  time  period.
n  age  groups,  1—5  and  6—15  year  females  were
ore predisposed  than  males  to  UTI  (Fig.  1).
Among aminoglycosides,  the  maximum  values  of
6%, 43%  and  50%  of  S.  aureus  isolates  were  resis-
ant to  the  antibiotics  amikacin  30,  gentamicin  10
nd netilmicin  30  g/disk,  respectively.  The  per-
ent resistant  values  of  the  -lactam  group  were
imilar (Table  2).  Among  the  -lactam  antibiotics,
iperacillin 100  g/disk  had  the  highest  percent
esistant isolates;  the  resistance  pattern  slightly
ecreased  in  the  following  order:  ceftazidime  30,
efuroxime  30,  piperacillin/tazobactam  100/10,
mpicillin  10,  ceftriaxone  30  and  amoxyclav
0 g/disk.  For  amoxyclav  30  g/disk,  36%  of  E.  coli
solates  had  the  highest  percent  of  resistance.  For
mpicillin  10  and  piperacillin  100  g/disk,  40%  of  E.
erogenes  isolates  were  resistant.  Approximately
8% of  E.  coli  isolates  had  the  highest  percent
alue of  resistance  over  piperacillin/tazobactam
00/10  g/disk.  A  36%  percent  resistance  value  in
. coli  isolates  was  recorded  as  the  highest  value
gainst  ceftriaxone  30  g/disk.  For  ceftazidime
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0  g/disk,  35%  of  E.  faecalis  and  P. aeruginosa
ecorded the  individual  highest  resistance  value.
or cefuroxime  30  g/disk,  34%  of  E. aerogenes
ecorded the  highest  resistance  value.
Similarly,  for  the  ﬂuoroquinolone  group,  E. aero-
enes  was  found  to  be  most  resistant  organism  to
evoﬂoxacin  5  g/disk  with  40%  and  K.  oxytoca  the
east, with  25%.  Again,  for  norﬂoxacin  10  g/disk,  P.
ulgaris was  the  most  resistant  organism  (38%)  and
. pneumoniae  the  least  with  a  resistance  percent-
ge value  of  27%.  Further,  for  oﬂoxacin  5  g/disk,
. aureus  isolates  had  the  maximum  resistance  val-
es with  39%,  whereas  C.  freundii  had  the  least
esistance with  23%.  Surprisingly,  co-trimoxazole
5 g/disk  was  found  resistance  for  40%  of  isolates
f E.  aerogenes  and  39%  of  isolates  of  S.  aureus
n this  hospital.  For  nitrofurantoin  300  g/disk,
he maximum  resistance  percent  value  was  found
s 34%  for  C.  freundii  and  P.  aeruginosa  isolates
Table  2).
iscussion
solates  of  both  GPs  were  vancomycin  resistant
nd all  GNs  were  resistant  to  nitrofurantoin  and
o-trimoxazole,  the  most  preferred  antibiotics  pre-
cribed in  empiric  therapy  against  UTI  in  this
egion [7]. In  another  study  based  in  India,  UTI-
ausing  bacteria  were  reported  to  be  resistant
o antibiotics  to  the  following  degrees:  83.3%  to
rimethoprim/sulfamethoxazole,  80.6%  to  nalidixic
cid, 67.3%  to  amoxicillin,  61%  to  co-trimoxazole,
8.8% to  gentamicin,  46%  to  ciproﬂoxacin  and  43%
o cephalexin  [13]. Community  surveillance  for
ropathogens  in  a  rural  setting  was  conducted  in
amil Nadu,  India;  from  this,  22.78%  of  1359  urine
amples were  found  positive  for  some  of  the  most
ommon  bacterial  uropathogens:  Staphylococcus
p., Streptococcus  sp.,  Enterococcus  sp.,  Klebsiella
p., Proteus  sp.  and  E.  coli.  Furthermore,  antibi-
grams  of  all  the  reported  genera  revealed  multiple
rug resistance  within  each  [14]. Previous  studies
onducted  in  different  types  of  Indian  rural  settings
ake clear  that  environment  plays  a signiﬁcant  role
n the  spread  of  MDR  pathogenic  bacteria  [15—17].
rom Iran,  it  was  reported  that  adult  patients  in  ICU
ith sepsis  had  higher  prevalence  of  MDR  bacteria
ausing  UTIs  [18].  UTI  is  known  to  cause  signif-
cant levels  of  morbidity  in  developed  countries
19]; thus,  morbidity  of  MDR  UTI-causing  bacteria
as become  a global  concern.
Resistance  to  aminoglycosides  and  -lactams,
ncluding cephalosporins  and  ﬂuoroquinolone,  is  of
reat concern  in  clinical  management,  particularly
s it  applies  to  children  because  their  immune
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systems  are  undeveloped  [20].  The  unfortunate
situation is that  most  pathogenic  bacteria  have
drug-resistant  characters  exchanged  through  the
operative  genetic  exchange  mechanisms  which  pro-
mote survival  in  a  new  host.  Further,  a report
from London  described  how  urine  dipstick  analy-
sis, which  measures  the  presence  or  absence  of
nitrites,  can  serve  as  a  prognostic  criterion  in
antibiotic-sensitivity  pattern  in  most  common  bac-
terial uropathogens.  It  was  observed  that  in  nitrite
positive  infants  and  children,  certain  groups  of
bacteria  were  signiﬁcantly  resistant  to  ceﬁxime
(third generation  cephalosporin,  3GC),  whereas
nitrite negative  patients  had  signiﬁcantly  increased
resistance  rate  with  other  bacteria.  For  example,
the London  study  observed  amoxicillin  and  amoxi-
cillin clavulanate  resistance  in  nitrite  negative  UTI
cases [21].  While  nitrofurantoin  and  3GCs  were
effective  among  nitrite  negative  afebrile  pediatric
UTI cases,  they  were  ineffective  among  febrile
infants with  UTI  [21]. In  the  present  study,  34%  of
isolates were  resistant  to  nitrofurantoin  in  vitro.
In a  study  conducted  in  Iran,  hospitalized  children
with UTI  problems  were  given  chemoprophylaxis
with trimethoprim/sulfamethoxazole,  nitrofuran-
toin or  cephalosporins.  The  recorded  resistant
pattern was  according  to  the  particular  antibiotic
used; nitrofurantoin  was  resistant  to  100%  of  Pseu-
domonas  sp.  isolates  [22]. In  a  study  in  Belgium,
infants less  than  3  months  old  were  found  to  be  at
risk for  UTI  (21%  of  all  children);  the  study  popula-
tion was  made  up  of  26%  females  and  74%  males,
with the  usual  occurrence  of  E.  coli  as  the  pre-
dominate causative  organism  [23].  In  the  present
study,  in  the  age  group  of  1—12  months,  males  were
more predisposed  to  UTI  than  females;  however,
in age  groups  1—5  years  and  6—15  years,  females
were more  predisposed  than  males  to  UTI.  Over-
all, 48%  of  children  had  a  UTI.  Longer  hospital
stays (6  days  versus  4 days)  caused  infections  from
extended  spectrum  -lactamase  producing  orga-
nisms in  UTI  cases  in  Israel,  with  the  predominance
of E.  coli  and  Klebsiella  sp.  [24]. UTI  was  reported
to occur  in  1—5%  of  children  with  recurrence  in
Oulu, Finland  [25].  In  a  Nigerian  hospital,  it  was
recorded  that  UTI  occurred  in  9%  of  febrile  chil-
dren aged  1—60  months  with  a  higher  prevalence
among girls  [26]. In Abidjan  (Western  Africa),  it
was reported  that  common  uropathogens  including
E. coli  and  Klebsiella  sp.  had  considerably  higher
rates of  resistance  for  amoxicillin  >  tetracycline  >
trimethoprim/sulfamethoxazole,  in  this  order  [27].MDR isolates  of  GPs  (Staphylococci  and  Ente-
rococci) precipitate  episodes  of  suppurative
infection that  are  notoriously  difﬁcult  to  control
[9,10]  because  most  isolates  remain  resistant  to
C
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-lactams.  The  superbug  of  the  health  domain,
RSA, is  widespread  [28]. Moreover,  for  the  control
f E.  coli  infections  aminoglycosides,  -lactams
nd ﬂuoroquinolones  are  generally  used  every-
here. When  E.  coli  isolates  are  simultaneously
esistant  to  several  antibiotics  of  the  cited  groups,
he consequent  therapeutic  problems  challenge
he cleanly  state  of  hospital  indoor  units  [7,29].
ndeed, the  emergence  of MDR  isolates  of  E.  coli
hreaten  the  use  of  antibiotics  which  poses  a  major
hallenge  to  the  health  care  system.  The  present
ntibiogram of E. coli  conﬁrms  such  resistance
n this  region.  The  hospital  in  this  study  reported
 fatal  neonatal  case  of  septicemia  due  to  MDR
. pneumoniae  [30]; clearly,  antibiotic  resistant
acteria have  consequences  in  pediatric  patients.
he present  study  and  similar  studies  clearly
ndicate that  the  high  prevalence  of  MDR  strains
f pathogenic  bacteria  are  a  cause  of  morbidity  in
atients of  the  pediatric  age  group.
As a limitation,  it  could  be  stated  that  previous
istory of  use  of  antibiotics  for  older  children  (6—15
ears of  age)  were  not  known,  while  the  admit-
ed infants  and  under-5  children  had  no  history  of
ntibiotic  use.
onclusion
ll  bacterial  isolates  from  urine  samples  of  infants
nd children  of  a typical  community  were  resistant
o most  current  antibiotics.  The  18  month  surveil-
ance  of  pediatric  UTI  revealed  that  MDR  isolates
f 9 pathogenic  GP  and  GN  bacteria  were  preva-
ent in  the  environment  around  the  hospital.  These
ndings  suggest  a need  for  revisions  to  the  present
ntimicrobial  stewardship  program  and  the  use  of
itrofurantoin,  ceftriaxone  and  cefuroxime  in  this
rea of  the  country.  This  would  ensure  clinician
onﬁdence in  empiric  therapy,  which  is  commonly
sed, e.g.,  for  surgical  sites  including  UTI  cases.
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